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INTRODUCTION
Diabetes mellitus is one of the most common chronic diseases 
in the world, and type 2 diabetes mellitus (T2DM) accounts for 
about 90% of all diabetes worldwide. Diabetes also has become 
one of the major causes of premature illness and death in most 
countries.[1] Given the large population, Chinese bear a higher 
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ABSTRACT
The aim of this study is to explore the correlation of laboratory data, hormone peptides, and quality of life with different traditional Chinese 
medicine (TCM) syndrome groups in type 2 diabetes patients. Of 513 registered patients, 179 subjects aged between 20 and 65 years 
and having type 2 diabetes mellitus (T2DM) for more than 1 year were enrolled in the study. All the participants were asked to fill out 
a questionnaire on diabetic TCM syndrome groups, which was designed by professional TCM doctors, and two questionnaires on the 
quality of life (QOL), WHOQOL‑BREF Taiwan version and Medical Outcomes Study (MOS) Short Form‑12 (SF‑12). The biochemical 
characteristics and hormone peptide levels were collected at the same time. The patients in any one of the six TCM syndrome groups had 
the trend to have worse QOL. Especially, patients with qi deficiency had worse life quality on every aspect compared to those without qi 
deficiency and were fatter than others. We also found that the subjects who had qi deficiency, qi stagnation, and yin deficiency at the same 
time had worsened condition. We consider that patients with qi deficiency may also be at a higher risk of developing other complications. 
They need more advanced health care than others. This self‑reported questionnaire will be a reference for health care workers screening 
those T2DM patients who have a higher possibility of developing other complications. Especially in remote areas, where there is a lack 
of medical resources, an easy‑to‑use tool such as the one in the present study for detecting and evaluating disease conditions is needed.
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diabetes‑related burden than any other country.[2‑4] Further, the 
high usage rate of traditional Chinese medicine (TCM) in Chinese 
population means TCM plays an important role in diabetes treat‑
ment in the Chinese population.
To improve long‑term diabetic syndromes, patients and 
health care professionals seek TCM as an adjuvant treatment for 
T2DM.[5,6] According to TCM theory, the physicians look at pat‑
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terns of disharmony, which include all presenting signs of illness 
and symptoms as well as patients’ emotional and psychological 
responses.[7] The physicians can classify the diabetic patients with 
different symptoms into different syndrome groups.
Many studies have shown the quality of life (QOL) of T2DM 
patients significantly decreases.[7‑10] The variation in syndrome groups 
could significantly influence some domains of QOL.[9] In our previous 
study, we developed a self‑reported questionnaire on symptoms to 
facilitate the classification of different syndrome groups for differ‑
ent diseases.[11‑13] Hence, we also want to examine the relationship 
among the diabetic TCM syndrome groups, QOL, and biochemical 
characteristics in T2DM patients. The aim of this study is to explore 
the correlation of lab data, hormone peptides, and QOL with different 
TCM syndrome groups in type 2 diabetes patients.
MATERIALS AND METHODS
Study design and participants
This was a cross‑sectional study conducted from January 2012 
through June 2012 in a Taipei City Hospital, Taiwan. Among the 
501 registered type 2 diabetes patients screened at our outpatient 
clinic, a total of 179 were enrolled. The inclusion criteria and exclu‑
sion criteria are shown in Table 1. The protocol was approved by 
the Human Ethics Committee of the Taipei City Hospital. Informed 
consent was obtained from all the enrolled patients.
Diabetic TCM syndrome groups
The enrolled subjects were examined by TCM practitioners, 
and diagnoses were made on the basis of the examination, symp‑
toms reported by the patients, and the practitioner’s experience. 
We developed a self‑reported questionnaire on patient symptoms 
as a diagnostic tool according to TCM concepts, our clinical ex‑
periences, and related studies,[11‑13] and the six most common TCM 
syndrome groups of T2DM patients were defined. These groups 
were respectively characterized by Stomach Heat syndrome (胃熱 
Wèi Rè, SHS), Yin Deficiency syndrome (陰虛 Yīn Xū, YDS), 
Qi Deficiency syndrome (氣虛 Qì Xū, QDS), Kidney Deficiency 
syndrome (腎虛 Shèn Xū, KDS), Qi Stagnation syndrome (氣滯 
Qì Zhì, QSS), and Spleen Deficiency syndrome (脾虛 Pí Xū, 
SDS). Nine TCM doctors with clinical experience met and came 
up with three yes–no questions under each syndrome group for 
diagnosing T2DM patients. The questionnaire designed is shown 
in Table 2. All patients were categorized into these six diabetic 
TCM syndrome groups if they met the diagnosed criteria having 
more than two out of three of the symptoms of the corresponding 
TCM syndrome. Validation test results showed an alpha coefficient 
of 0.85 and Cronbach’s alpha coefficient of 0.78, indicating that 
the questionnaire has good reliability.
Quality of life
To measure the QOL among our subjects, we used the 
self‑administered questionnaire of brief version of World Health 
Organization Quality of Life (WHOQOL‑BREF), Taiwan ver‑
sion, which was well validated with consistency coefficients 
ranging from 0.70 to 0.77.[14] The WHOQOL‑BREF question‑
naire evaluated the QOL in physical, psychological, social, and 
environmental domains, with scores ranging from 0 to 100. We 
also used another self‑administered questionnaire, Medical Out‑
comes Study (MOS) Short Form‑12 (SF‑12), which has 12 items. 
These 12 items measure eight concepts: Physical functioning, role 
limitations due to physical health problems, role limitations due 
to emotional health problems, bodily pain, general health, vital‑
ity, social functioning, and mental health. The responses of these 
questions are transformed into two scores, physical and mental 
composite score (PCS‑12 and MCS‑12), respectively. The general 
population has a mean of 50 and a standard deviation of 10.[15,16] 
Higher scores represent a better health condition.
Table 1. Inclusion and exclusion criteria
Inclusion criteria
Aged between 20 and 65 years
Having type 2 diabetes for more than 1 year
Willing to participate in this study
Exclusion criteria
Glutamate pyruvate transaminase≥80 mg/dl
Serum creatinine≥1.8 mg/dl
Prolactin or pregnant women and planned‑to‑pregnant women
Heart failure, acute myocardial infarction, stroke, and heavy injuries 
in 6 months
Any other conditions not suitable for trial as evaluated by the 
physician
Table 2. Classification criteria for the diagnosis of TCM deficiency 
syndrome groups
In the past week, did you often have the following symptoms?
(Often means more than 8 h/day and more than 4 days/week)
Stomach Heat syndrome (胃熱 Wèi Rè)
Sore gums or bad breath
Swift digestion with frequent hunger
Like to drink cold beverages
Yin Deficiency syndrome (陰虛 Yīn Xū)
Dry throat or mouth
Night sweats
Palm or face flushing sensation
Qi Deficiency syndrome (氣虛 Qì Xū)
Felt exhausted or lack of energy
Did not feel like talking or talked in a low and weak voice
Did not feel like moving about or did not have the strength to walk
Kidney Deficiency syndrome (腎虛 Shèn Xū)
Felt backache easily
Tinnitus and hard of hearing
Frequent urination (more than two times in the night)
Qi Stagnation syndrome (氣滯 Qì Zhì)
Chest tightness
Palpitation
Agitation and irritability
Spleen Deficiency syndrome (脾虛 Pí Xū)
Leg pitting edema
Felt thirsty and like to drink water easily
Anorexia
Definition: Patients who have two of three or more of the criteria in 
the Stomach Heat; Yin Deficiency; Qi Deficiency; Kidney Deficiency; 
Qi Stagnation; and Spleen Deficiency syndrome groups are compatible with 
that TCM syndrome; TCM: Traditional Chinese medicine
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Analysis of hormone peptides
The levels of hormone peptides, including leptin, insulin, 
ghrelin, and adiponectin, were measured in the morning after 
8‑9 h of fasting. The entire blood sample was drawn and centri‑
fuged at 4°C, with 1 ml of the sample rapidly frozen at −80°C 
for the subsequent radioimmunoassay concentration analysis. 
Leptin was detected by the Human Leptin assay (Millipore, St. 
Charles, MO, USA) using I125‑labled human leptin antiserum 
with a sensitivity of 0.5 ng/ml for a 100‑μl sample. Ghrelin and 
adiponectin were detected by Ghrelin RIA Kit (Millipore) and 
Adiponectin RIA kit (Millipore) with a sensitivity of 93 pg/
ml and 1 ng/ml, respectively. We used the same process as 
that for leptin detection only with different I125‑labled antibod‑
ies specific for ghrelin or adiponectin. BioSource INS‑IRMA 
Kits (BioSource Europe S.A., Nivelles, Belgium) were employed 
to determine the level of insulin in the serum as previously re‑
ported.[17,18] Sampling would be reported if a difference exceed‑
ing 10% coefficient of variation was found between duplicated 
results of the sample. Following the approach of Matthews, 
et al., we used the homeostasis model assessment for insulin 
resistance (HOMA‑IR) for measuring the insulin resistance of 
our subjects.[19]
Outcome measurements
The major outcome is the difference in lab data and QOL 
scores of T2DM patients in different diabetic TCM syndrome 
groups. We included the mean scores of WHOQOL‑BREF and 
SF‑12 questionnaire, body mass index (BMI), and biochemical 
characteristics in the six TCM syndrome groups at the same time.
The biochemical characteristics of the blood sample included 
fasting blood sugar, triglyceride, total cholesterol levels, and 
hormone peptides also. The other outcomes were evaluated in 
terms of weight, waist circumference, hip circumference, and 
blood pressure.
All patients were asked to answer the TCM syndrome group 
questionnaire to classify them into six diabetic TCM syndrome 
groups. All biochemical measurements were made after 8‑9 h of 
fasting using a standardized method, as detailed in our previous 
research.[20] The physicians who participated in the study received 
prior training before the study and they also knew how to interview 
the patients and assist them in completing the questionnaires.
Statistical analysis
The data were analyzed by SPSS software (version 17.0, 
Chicago, IL, USA). Student’s t‑test was employed to examine 
the demographic data, basic data, biochemical data, hormone 
peptide data, and QOL scores. Multiple linear regression analysis 
with the stepwise method was applied to adjust the QOL scores. 
All P values were two‑tailed and the α level of significance was 
set at 0.05.
RESULTS
Demographics and clinical features of subjects
Of 501 registered patients with diabetes screened at our 
outpatient clinic, 179 subjects met the inclusion and exclusion 
criteria. All of these 179 subjects completed both questionnaires. 
As shown in Figure 1, QDS is the most common syndrome group 
in this study. There were 44% subjects with QDS. The mean age, 
BMI, systolic/diastolic blood pressure, and triglyceride level of all 
the subjects in the study were 54.3 ± 7.1 years, 26.5 ± 4.4 kg/m2, 
133.8 ± 17.5/80.2 ± 11.6 mmHg, and 179.0 ± 83.3 mg/dl, respec‑
tively [Table 3].
Figure 1. Distribution of different diabetic syndrome groups (a, Stomach 
Heat syndrome [胃熱 Wèi Rè, SHS]; b, Yin Deficiency syndrome [陰虛 Yīn 
Xū, YDS]; c, Qi Deficiency syndrome [氣虛 Qì Xū, QDS]; d, Kidney 
Deficiency syndrome [腎虛 Shèn Xū, KDS]; e, Qi Stagnation syndrome 
[氣滯 Qì Zhì, QSS]; f, Spleen Deficiency syndrome[脾虛 Pí Xū, SDS])
Table 3: Demographic characteristics of the participants
Variables All (N=179)
Basic data
Age, years 54.3 (7.1)
Body mass index, kg/m2 26.5 (4.4)
Waist circumference, cm 86.6 (10.5)
Hip circumference, cm 98.0 (9.3)
Waist/hip 0.9 (0.1)
Heart rate, times/min 77.7 (12.8)
Systolic blood pressure, mmHg 133.8 (17.5)
Diastolic blood pressure, mmHg 80.2 (11.6)
Biochemical data
Fasting blood sugar, mg/dl 147.0 (51.7)
HbA1c, % 7.7 (1.7)
Triglyceride, mg/dl 179.0 (83.3)
Total cholesterol, mg/dl 203.3 (44.6)
High density lipoprotein, mg/dl 49.3 (13.1)
Low density lipoprotein, mg/dl 112.7 (32.5)
Glutamate pyruvate transaminase, IU/L 32.4 (20.0)
Creatinine, mg/dl 0.7 (0.2)
Uric acid, mg/d 5.4 (1.3)
HOMA‑IR index 5.1 (3.6)
Hormone peptide
Leptin, ng/ml 8.0 (6.1)
Adiponectin, µg/ml 20.1 (4.9)
Ghrelin, pg/ml 515.5 (225.3)
Insulin, IU/ml 14.2 (10.1)
The data are presented as mean (SD), HbA1c: Hemoglobin A1c; 
HOMA‑IR: Homeostasis model assessment for insulin resistance
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Basic data
Table 4 shows the difference in basic data among the six 
diabetic TCM syndrome groups. As shown in the table, there was 
significant difference in BMI, waist circumference, hip circumfer‑
ence, and systolic blood pressure between the patients with and 
without QDS; that is, type 2 diabetes patients with QDS were fatter 
than those patients without QDS. The patients with KDS also had 
higher BMI than those without KDS, and the patients with SDS 
were significant older than others.
Biochemical characteristics and hormone peptides
As seen in Table 5, the subjects with YDS, QDS, and QSS 
had significantly higher triglyceride levels than those without 
syndromes.
Table 4: Difference in basis data among the different diabetic traditional Chinese medicine syndrome groups
Variables SHS YDS QDS KDS QSS SDS
Yes 
(n=33)
No 
(n=146)
Yes 
(n=36)
No 
(n=143)
Yes 
(n=79)
No 
(n=100)
Yes 
(n=66)
No 
(n=113)
Yes 
(n=44)
No 
(n=135)
Yes 
(n=26)
No 
(n=153)
Basic data
Age, years 52.2 
(8.3)
54.7 
(6.7)
54.1 
(7.6)
54.3 
(7.0)
54.9 
(7.8)
53.8 
(6.5)
55.0 
(7.1)
53.9 
(7.1)
54.3 
(6.1)
54.3 
(7.4)
57.7 
(7.2)*
53.7 
(6.9)*
BMI, kg/m2 25.6 
(4.1)
26.7 
(4.5)
27.2 
(4.6)
26.3 
(4.4)
28.3 
(4.3)**
25.1 
(4.1)**
27.5 
(4.7)*
25.9 
(4.2)*
27.4 
(4.5)
26.2 
(4.4)
27.0 
(4.0)
26.4 
(4.5)
Waist, cm 87.2 
(10.8)
86.4 
(10.5)
86.5 
(9.9)
86.6 
(10.7)
89.9 
(10.5)**
83.9 
(9.7)**
88.1 
(10.4)
85.7 
(10.5)
86.6 
(10.9)
86.6 
(10.4)
87.0 
(10.6)
86.5 
(10.5)
Hip, cm 96.9 
(7.6)
98.2 
(9.6)
99.0 
(9.4)
97.7 
(9.3)
100.9 
(9.9)**
95.6 
(8.0)**
99.5 
(9.6)
97.1 
(9.0)
99.9 
(10.3)
97.4 
(8.9)
97.2 
(6.9)
98.1 
(9.6)
Waist/hip 0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 (0.1) 0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
0.9 
(0.1)
HR, 
times/min
79.8 
(12.9)
77.2 
(12.7)
80.2 
(14.8)
77.0 
(12.2)
77.4 
(13.9)
77.9 
(11.8)
76.5 
(12.5)
78.4 
(12.9)
74.3 
(11.3)*
78.8 
(13.1)*
70.0 
(13.1)*
79.0 
(12.3)*
SBP, mmHg 134.2 
(16.0)
133.8 
(17.9)
135.5 
(18.8)
133.4 
(17.2)
137.6 
(18.1)*
130.9 
(16.5)*
135.8 
(17.0)
132.7 
(17.8)
135.0 
(18.3)
133.5 
(17.3)
136.9 
(18.3)
133.3 
(17.4)
DBP, mmHg 80.1 
(10.3)
80.3 
(11.9)
82.0 
(13.1)
79.8 
(11.2)
82.0 
(12.5)
78.8 
(10.7)
80.6 
(12.8)
80.0 
(10.9)
81.7 
(14.3)
79.7 
(10.6)
80.8 
(14.5)
80.1 
(11.1)
The data are presented as mean (SD), SHS: Stomach Heat syndrome (胃熱 Wèi Rè); YDS: Yin Deficiency syndrome (陰虛 Yīn Xū); QDS: Qi Deficiency 
syndrome (氣虛 Qì Xū); KDS: Kidney Deficiency syndrome (腎虛 Shèn Xū); QDS: Qi Stagnation syndrome (氣滯 Qì Zhì); SDS: Spleen Deficiency 
syndrome (脾虛 Pí Xū); HR: Hart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure, BMI: Body mass index, *P<0.05, **P<0.001
Table 5: Difference in biochemical data among the different diabetic traditional Chinese medicine syndrome groups
Variables SHS YDS QDS KDS QSS SDS
Yes 
(n=33)
No 
(n=146)
Yes 
(n=36)
No 
(n=143)
Yes 
(n=79)
No 
(n=100)
Yes 
(n=66)
No 
(n=113)
Yes 
(n=44)
No 
(n=135)
Yes 
(n=26)
No 
(n=153)
Biochemical data
Glucose, mg/dl 159.0 
(43.2)
144.3 
(53.1)
151.9 
(53.5)
145.7 
(51.3)
148.6 
(50.9)
145.7 
(52.5)
141.2 
(44.2)
150.4 
(55.5)
138.6 
(48.1)
149.7 
(52.7)
133.8 
(46.4)
149.2 
(52.3)
HbA1c, % 8.1 
(1.7)
7.5 
(1.7)
7.8 
(1.8)
7.6 
(1.6)
7.8 
(1.8)
7.5 
(1.5)
7.5 
(1.4)
7.8 
(1.8)
7.4 
(1.8)
7.7 
(1.6)
7.7 
(1.8)
7.6 
(1.7)
Triglyceride, 
mg/dL
197.1 
(83.8)
174.9 
(83.0)
222.4 
(70.2)**
168.1 
(83.0)**
198.5 
(80.1)*
163.6 
(83.0)*
194.0 
(81.7)
170.3 
(83.4)
203.3 
(75.1)*
171.1 
(84.6)*
188.7 
(81.0)
177.4 
(83.9)
T. chol., mg/dl 216.1 
(44.9)
200.5 
(44.2)
212.3 
(47.0)
201.1 
(43.9)
207.3 
(44.1)
200.2 
(45.0)
204.7 
(47.6)
202.5 
(43.0)
207.0 
(36.6)
202.1 
(47.0)
224.8 
(61.2)
199.7 
(40.3)
HDL‑C, mg/dl 48.6 
(12.9)
49.5 
(13.2)
46.4 
(11.4)
50.0 
(13.4)
48.4 
(11.0)
50.1 
(14.5)
47.7 
(10.2)
50.2 
(14.5)
48.6 
(11.9)
49.5 
(13.5)
53.6 
(18.0)
48.6 
(12.0)
LDL‑C, mg/dl 118.0 
(26.5)
111.5 
(33.7)
108.8 
(28.2)
113.6 
(33.5)
112.3 
(31.3)
113.0 
(33.6)
110.1 
(32.3)
114.2 
(32.7)
114.0 
(32.9)
112.2 
(32.5)
114.5 
(31.0)
112.4 
(32.8)
GPT, IU/L 35.0 
(25.5)
31.8 
(18.6)
33.9 
(17.2)
32.0 
(20.6)
36.3 
(22.9)*
29.4 
(16.8)*
34.3 
(21.6)
31.3 
(19.0)
32.2 
(17.5)
32.5 
(20.8)
29.9 
(19.1)
32.8 
(20.1)
Creatinine, mg/dl 0.7 
(0.1)
0.7 
(0.2)
0.8 
(0.2)
0.7 
(0.2)
0.7 
(0.2)
0.8 
(0.2)
0.7 
(0.1)
0.7 
(0.2)
0.8 
(0.2)
0.7 
(0.2)
0.8 
(0.1)
0.7 
(0.2)
Uric acid, mg/dl 5.2 
(1.1)
5.5 
(1.3)
5.1 
(1.1)
5.5 
(1.3)
5.5 
(1.2)
5.4 
(1.4)
5.4 
(1.2)
5.5 
(1.3)
5.5 
(1.3)
5.4 
(1.3)
5.3 
(1.6)
5.5 
(1.3)
The data are presented as mean (SD), SHS: Stomach Heat syndrome (胃熱 Wèi Rè); YDS: Yin Deficiency syndrome (陰虛 Yīn Xū); QDS: Qi Deficiency 
syndrome (氣虛 Qì Xū); KDS: Kidney Deficiency syndrome (腎虛 Shèn Xū); QSS: Qi Stagnation syndrome (氣滯 Qì Zhì); SDS: Spleen Deficiency 
syndrome (脾虛 Pí Xū); HbA1c: Hemoglobin A1c; T. chol.: Total cholesterol; HDL‑C: High density lipoprotein cholesterol; LDL‑C: Low density lipoprotein 
cholesterol; GPT: Glutamate pyruvate transaminase, *P<0.05, **P<0.001
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As for hormone peptides [Table 6], the leptin, insulin, and 
HOMA‑IR index levels were markedly higher in subjects with QDS. 
The leptin and ghrelin levels were also significantly higher in KDS 
group, while the adiponectin level of the subjects with QSS was sig‑
nificantly lower but leptin level was higher than those without QSS.
QOL scores
Table 7 displays the intergroup analysis among the subjects 
with/without the six TCM diabetic syndromes. We observe that 
the subjects with QDS had significantly lower QOL scores on 
every aspect of the WHOQOL‑BREF survey and the same was 
found in the SF‑12 survey. It is evident that QDS significantly 
affected the QOL in the WHO‑BREF physical, psychologi‑
cal (P < 0.001), social relations (P < 0.05), environment do‑
main (P  < 0.001), and both physical and mental aspects in 
SF‑12 (P < 0.001). The subjects with KDS also had significantly 
lower QOL scores on every aspect of both WHOQOL‑BREF 
survey and SF‑12 survey, except MCS‑12 in SF‑12 survey. 
With respect to with/without QSS groups, there was significant 
difference in MCS‑12 score and the subjects with QSS had a 
lower score.
Table 8 shows the coefficients of linear multiple regressions 
on QDS’s QOL scores of the WHOQOL‑BREF and SF‑12 survey 
by the stepwise method. We adjusted the basic data including 
age, gender, family history of type 2 diabetes, and blood pres‑
sure, and also adjusted the biochemical data such as glycosyl‑
ated hemoglobin (HbA1c), triglyceride, total cholesterol, high 
density lipoprotein (HDL), and low density lipoprotein (LDL). 
We also adjusted the hormone peptides like leptin, adiponectin, 
ghrelin, and HOMA‑IR. In Table 8, it is found that females 
showed a significant correlation with a better score in the social 
domain of the WHOQOL‑BREF survey, but poor PCS‑12 in 
Table 6: Difference in hormone peptides among the different diabetic traditional Chinese medicine syndrome groups
Variables SHS YDS QDS KDS QSS SDS
Yes 
(n=33)
No 
(n=146)
Yes 
(n=36)
No 
(n=143)
Yes 
(n=79)
No 
(n=100)
Yes 
(n=66)
No 
(n=113)
Yes 
(n=44)
No 
(n=135)
Yes 
(n=26)
No 
(n=153)
Hormone peptide
Leptin, ng/ml 6.9 
(4.1)
8.2 
(6.4)
9.1 
(7.7)
7.8 
(5.6)
10.2 
(7.3)**
6.3 
(4.2)**
9.7 
(7.4)*
7.1 
(4.9)*
9.9 
(7.3)*
7.4 
(5.5)*
9.8 
(7.9)
7.7 
(5.7)
Adiponectin, 
µg/ml
19.2 
(3.7)
20.2 
(5.1)
18.7 
(2.6)*
20.4 
(5.3)*
19.6 
(4.8)
20.4 
(4.9)
20.2 
(5.7)
19.9 
(4.4)
18.2 
(1.4)*
20.6 
(5.4)*
21.4 
(8.5)
19.8 
(3.9)
Ghrelin, pg/ml 479.4 
(236.1)
522.6 
(223.3)
525.2 
(193.7)
513.1 
(233.1)
532.7 
(235.8)
502.4 
(217.2)
564.0 
(232.9)*
487.2 
(216.8)*
519.5 
(194.0)
514.3 
(235.0)
592.7 
(255.8)
502.3 
(217.9)
Insulin, IU/ml 14.2 
(6.4)
14.2 
(10.7)
15.8 
(9.6)
13.8 
(10.2)
16.1 
(11.9)*
12.7 
(8.3)*
15.1 
(11.9)
13.7 
(8.9)
17.0 
(11.3)
13.3 
(9.6)
16.1 
(11.6)
13.9 
(9.8)
HOMA‑IR 
index
5.7 
(2.7)
5.0 
(3.8)
5.8 
(3.4)
4.9 
(3.7)
5.8 
(3.9)*
4.6 
(3.4)*
5.2 
(4.0)
5.0 
(3.4)
5.8 
(3.7)
4.9 
(3.6)
5.2 
(3.3)
5.1 
(3.7)
The data are presented as mean (SD), SHS: Stomach Heat syndrome (胃熱 Wèi Rè); YDS: Yin Deficiency syndrome (陰虛 Yīn Xū); QDS: Qi Deficiency 
syndrome (氣虛 Qì Xū); KDS: Kidney Deficiency syndrome (腎虛 Shèn Xū); QSS: Qi Stagnation syndrome (氣滯 Qì Zhì); SDS: Spleen Deficiency 
syndrome (脾虛 Pí Xū); HOMA‑IR: Homeostasis model assessment for insulin resistance, *P<0.05, **P<0.001
Table 7: Comparison of life quality in yes/no TCM syndrome group
Variables SHS YDS QDS KDS QDS SDS
Yes 
(n=33)
No 
(n=146)
Yes 
(n=36)
No 
(n=143)
Yes 
(n=79)
No 
(n=100)
Yes 
(n=66)
No 
(n=113)
Yes 
(n=44)
No 
(n=135)
Yes 
(n=26)
No 
(n=153)
WHOQOL‑BREF
Physical 58.8 
(14.4)*
64.9 
(12.4)*
61.7 
(14.2)
64.3 
(12.7)
57.4 
(12.2)**
69.0 
(11.3)**
59.4 
(12.6)**
66.4 
(12.5)**
58.5 
(15.2)*
65.6 
(11.7)*
61.2 
(10.5)
64.3 
(13.3)
Psychological 70.0 
(14.8)
72.1 
(15.2)
68.6 
(14.2)
72.5 
(15.3)
66.8 
(15.0)**
75.7 
(14.0)**
68.1 
(16.9)*
73.9 
(13.6)*
64.3 
(16.8)*
74.2 
(13.7)*
68.3 
(16.8)
72.3 
(14.8)
Social 70.2 
(14.2)
74.5 
(17.2)
71.1 
(17.5)
74.3 
(16.5)
70.9 
(17.2)*
75.9 
(16.0)*
69.2 
(20.6)*
76.4 
(13.3)*
71.6 
(18.0)
74.4 
(16.2)
71.2 
(15.6)
74.1 
(16.9)
Environment 70.0 
(12.5)
74.9 
(13.9)
73.3 
(11.5)
74.2 
(14.3)
69.7 
(14.1)**
77.5 
(12.6)**
71.3 
(14.5)*
75.6 
(13.1)*
71.6 
(12.6)
74.8 
(14.1)
71.0 
(12.9)
74.5 
(13.9)
SF‑12
PCS‑12 44.3 
(10.4)
47.5 
(7.6)
44.7 
(9.5) 
47.6 
(7.8)
43.4 
(8.3)**
49.9 
(6.9)**
43.1 
(9.5)**
49.3 
(6.3)**
43.5 
(10.2)*
48.2 
(7.1)*
43.3 
(8.5)*
47.7 
(8.0)*
MCS‑12 46.6 
(10.9)
50.2 
(9.5)
45.6 
(9.6)*
50.6 
(9.6)*
46.5 
(10.0)**
52.1 
(8.9)**
47.8 
(10.9)
50.7 
(9.0)
43.7 
(10.6)**
51.5 
(8.7)**
48.7 
(8.4)
49.8 
(10.0)
The data are presented as mean (SD), SHS: Stomach Heat syndrome (胃熱 Wèi Rè); YDS: Yin Deficiency syndrome (陰虛 Yīn Xū); QDS: Qi Deficiency 
syndrome (氣虛 Qì Xū); KDS: Kidney Deficiency syndrome (腎虛 Shèn Xū); QDS: Qi Deficiency syndrome (氣滯 Qì Zhì); SDS: Spleen Deficiency 
syndrome (脾虛 Pí Xū); PCS: Physical condition score; MCS: Mental condition score; *P<0.05, **P<0.001, SF: Short form; TCM: Traditional Chinese 
medicine; WHOQOL‑BREF: Brief version of World Health Organization Quality of Life
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the SF‑12 survey. As seen in the WHOQOL‑BREF survey in 
Table 8, aging people showed a marked correlation with a higher 
score in every domain, but only showed significant correlation 
with MCS in the SF‑12 survey. The subjects with QDS showed 
a markedly significant correlation with poor scores in every 
domain, except the social domain, on both the WHOQOL‑BREF 
and SF‑12 surveys.
Correlation among six diabetic TCM syndrome groups
Table 9 shows the coexisting correlation among the six diabetic 
TCM syndrome groups. QDS had significantly high co‑exiting 
correlation with every other syndrome group, except SHS group. 
QSS group had the same condition with QDS group. YDS group 
had high co‑exiting correlation with QDS, QSS, and KDS groups. 
The condition of SDS group was the same as YDS group. SHS 
group had no significant co‑exiting correlation with any other 
syndrome group.
DISCUSSION
The initial findings of our study showed T2DM patients with 
QDS had worse QOL scores. Among all T2DM patients in our 
study, the group with QDS accounted for about 44% of the total. 
They had lower QOL scores over the physical, psychological, 
social relations, and environment aspects than the group without 
QDS in the WHO‑BREF survey, as well as lower scores on every 
aspect of the SF‑12 survey [Table 7].
In terms of basic data, we found there were significant dif‑
ferences in BMI and waist and hip circumferences between the 
groups with/without QDS. The patients with QDS had higher 
BMI and larger waist and hip circumferences. As seen in Table 4, 
the triglyceride and the leptin levels of patients with QDS were 
higher than those without QDS. To prove that QDS is a really 
important factor in poor QOL, we adjusted many factors as seen 
in Table 8. According to TCM theory, QDS might cause patients 
to feel exhausted or lack energy. Patients with chronic symptoms 
of diabetes, such as tiredness and lethargy, leading to a decrease 
in work performance in adults and increased falls in the elderly. 
Obviously, the QOL of T2DM patients will be adversely affected.[5] 
We found that QDS affected the QOL deeply and adversely, even 
when adjusted by other related factors.
In the past, the study of TCM encountered serious challenges 
due to the almost irreconcilable differences with conventional 
western medicine. However, we found patients with QDS had 
higher BMI.[21] This matched the concept of TCM theory that 
patients with QDS are usually obese. Previous studies showed 
impaired biochemical data and hormone peptide level, such as 
insulin resistance, impaired adiponectin or leptin level and higher 
triglyceride level, not only adversely affected the health of the 
T2DM patients, but also badly affected their QOL.[22‑25] We ob‑
tained similar results. Fatty acids not only provide an important 
Table 8: Multiple linear regression analysis of the scores of quality of life using stepwise method
Factor WHOQOL‑BREF SF‑12
Physical Psychological Social Environmental PCS‑12 MCS‑12
β P β P β P β P β P β P
Sex (male=1/female=0) −0.01 0.87 −0.31 <0.05 −0.36 <0.001 −0.11 0.29 0.23 <0.05 −0.15 0.14
Family history of type 2 diabetes 
(yes=1/no=0)
0.09 0.21 0.08 0.29 0.10 0.19 0.03 0.69 0.15 <0.05 0.01 0.91
Age 0.28 <0.001 0.16 0.06 0.15 0.08 0.14 0.12 0.12 0.14 0.22 <0.05
BMI 0.14 0.17 0.24 <0.05 0.29 <0.05 0.12 0.29 0.10 0.31 0.30 <0.05
With/without Qi deficiency −0.46 <0.001 −0.28 0.001 −0.11 0.17 −0.27 <0.05 −0.34 <0.001 −0.39 <0.001
Adjusting: Systolic blood pressure, diastolic blood pressure, hemoglobin A1c (HbA1c), triglyceride, total cholesterol, high density lipoprotein cholesterol, low 
density lipoprotein cholesterol, leptin, adiponectin, ghrelin, homeostasis model assessment for insulin resistance (HOMA‑IR), BMI: Body mass index; PCS: 
Physical condition score; MCS: Mental condition score; SF: Short form; WHOQOL‑BREF: Brief version of World Health Organization Quality of Life
Table 9: Intergroup correlation analysis of different diabetic traditional 
Chinese medicine syndrome groups
SHS 
(%)
YDS 
(%)
QDS 
(%)
KDS 
(%)
QSS 
(%)
SDS 
(%)
SHS
With
Without
P
YDS
With 27.8
Without 16.1
P 0.11
QSS
With 24.1 31.6
Without 14.0 11.0
P 0.09 <0.05
KDS
With 22.7 34.8 69.7
Without 15.9 11.5 29.2
P 0.26 <0.001 <0.001
QSS
With 25.0 43.2 70.5 52.3
Without 16.3 12.6 35.6 31.9
P 0.20 <0.001 <0.001 <0.05
SDS
With 23.1 30.8 65.4 65.4 46.2
Without 17.6 18.3 40.5 32.0 20.9
P 0.51 0.14 <0.05 <0.05 <0.05
SHS: Stomach Heat syndrome (胃熱 Wèi Rè); YDS: Yin Deficiency 
syndrome (陰虛 Yīn Xū); QDS: Qi Deficiency syndrome (氣虛 Qì Xū); 
KDS: Kidney Deficiency syndrome (腎虛 Shèn Xū); QSS: Qi Stagnation 
syndrome (氣滯 Qì Zhì); SDS: Spleen Deficiency syndrome (脾虛 Pí Xū); 
PCS: Physical condition score; MCS: Mental condition score
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energy source as nutrients but also act as signaling molecules in 
various cellular processes.[26,27] It was also reported that the plasma 
fatty acid concentration in subjects with diabetes and pre‑diabetes 
was higher than that in healthy controls. The higher triglyceride 
level might be the reason for the development of metabolic syn‑
drome among T2DM patients and is also an important biomarker 
of QDS.[26,28] According to the previous study and the lab data 
of this study, patients with QDS might be predicted to develop 
metabolic syndrome and poor QOL.
According to the data of Table 5, Table 6, and the original 
data of the subjects’ TCM syndrome record, we found that the 
subjects who had QDS, QSS, and YDS at the same time had 
worsened conditions, like higher BMI, HOMA‑IR index, etc., 
The obese patients usually have bad blood circulation system. 
This may be the cause of qi and yin deficiency. YDS means ab‑
normal body fluid secretion or deficiency. Hence, we considered 
YDS group in this study may have correlation with abnormal 
secretion of hormone.
The yes–no questions of the different specific syndromes in 
this questionnaire came up from common intersection of nine 
TCM doctors with clinical experience diagnosing six traditional 
Chinese syndromes. Overlapping symptoms might exist among the 
six syndrome groups due to the complexity of the TCM concept, 
thus two or three mutually conclusive symptoms in the question‑
naire should be satisfied when diagnosing the different traditional 
Chinese syndromes. However, mutual existence of the different 
syndromes could be found in the same subject, which might influ‑
ence the specificity of the syndrome group. A large‑scale study 
is needed to further validate this questionnaire and improve its 
sensitivity and specificity.
CONCLUSION
The three yes–no questions for diagnosing the six diabetic 
TCM syndrome groups in this study which showed high coef‑
ficient on the validation test may be used as a screen tool for the 
health care workers evaluating the condition of T2DM patients. 
These three yes–no questions for diagnosing diabetic syndrome 
groups will be a reference for the health care workers screening 
those T2DM patients who have a higher possibility of developing 
other complications and poor QOL. Especially in remote areas, 
where there is lack of medical resources, an easy‑to‑use tool for 
detecting and evaluating disease conditions is needed.
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